The number of people with susceptibility test result for rifampicin in Côte d'Ivoire
Côte d'Ivoire: The number of people with susceptibility test result for rifampicin was 59.19 in 2021. ◆ Volatile
Latest (2021)
59.19
Change on year
up 493.8%
World rank
111th
of 146 countries
All-time high
59.19
in 2021
All-time low
7.45
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Côte d'Ivoire, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Côte d'Ivoire is 59.19, measured in 2021. That is the highest value across all 5 years on record.
The figure is up 493.8% on the previous year and up 694.1% over five years.
Côte d'Ivoire ranks 111th of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Côte d'Ivoire, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 7.45 | — |
| 2018 | 51.61 | +592.4% |
| 2019 | 11.23 | -78.2% |
| 2020 | 9.97 | -11.2% |
| 2021 | 59.19 | +493.8% |
Côte d'Ivoire compared with similar countries
- Côte d'Ivoire's 59.19 is below the median for lower middle income countries, which is 78.77, 75% of the median. (32 countries reporting)
- Côte d'Ivoire's 59.19 is below the median for Sub-Saharan Africa, which is 61.16, 97% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 23.43 | 7.45 | 51.61 | 3 |
| 2020s | 34.58 | 9.97 | 59.19 | 2 |
Countries ranked near Côte d'Ivoire
More health data for Côte d'Ivoire
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 864.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 32,592 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 12 (2025)
- Population ages 00-04, female, annual growth rate 1.01 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Côte d'Ivoire?
- The number of people with susceptibility test result for rifampicin in Côte d'Ivoire was 59.19 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Côte d'Ivoire?
- The highest recorded value was 59.19 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Côte d'Ivoire?
- The lowest recorded value was 7.45 in 2017.
- How does Côte d'Ivoire rank for the number of people with susceptibility test result for rifampicin?
- Côte d'Ivoire ranks 111th out of 146 countries with data for 2021.
- Where does this Côte d'Ivoire data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).